| Literature DB >> 35351086 |
M Dewulf1,2, N D Hildebrand3, S A W Bouwense3, N D Bouvy3, F Muysoms4.
Abstract
BACKGROUND: Parastomal hernia after ileal conduit urinary diversion is an underestimated and undertreated clinical entity, which heavily impairs patients' quality of life due to symptoms of pain, leakage, application or skin problems. As for all gastrointestinal stomata the best surgical repair technique has yet to be determined. Thereby, surgery for ileal conduit parastomal hernias poses some specific perioperative challenges. This review aims to give an overview of current evidence on the surgical treatment of parastomal hernia after cystectomy and ileal conduit urinary diversion, and on the use of prophylactic mesh at index surgery in its prevention.Entities:
Keywords: Cystectomy; Ileal conduit; Parastomal hernia
Mesh:
Year: 2022 PMID: 35351086 PMCID: PMC8966280 DOI: 10.1186/s12893-022-01509-y
Source DB: PubMed Journal: BMC Surg ISSN: 1471-2482 Impact factor: 2.102
Fig. 1PRISMA flow diagram of study selection
Study characteristics, surgical details and postoperative outcomes of included full-text articles
| Study characteristics* | Surgical details | Postoperative outcomes* | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Author & Year | Country | Study period | Sample size | Mean age | Male (%) | Surgical technique | Appr | Mesh repair | Mesh position | Mesh type | Post-OP compl. rate | CD Grade | Rec. rate | Length of follow-up | Type of follow-up | Length of stay | 30-day re-operation rate |
| Franks 2001 | USA | NR | 6 | (65–83) | NR | Keyhole | Open | Yes | Onlay | small pore, heavy weight | NR | NR | 0% | 26 m (2–42) | Clinical + CT | 2.5 d (2–5) | 0% |
| Helal 1997 | USA | 1990–1996 | 19 | 64.3(41–79) | 26% | Re- location | Open | Yes (†) | Onlay | small pore, heavy weight | NR | NR | 11% | 23.4 ± 15.25 m | NR | NR | NR |
| Ho 2004 | UK | 1982–2001 | 15 | (34–82) | 47% | Onlay mesh repair (‡) | Open | Yes | Onlay | small pore, heavy weight | 13% | 13% | 7% | 15 m (1–72) | NR | 4 d (2–14) | 13% |
| Lopez-Cano 2021 | Spain | 2012–2018 | 20 | 71 (SD:9.07) | 85,0% | Onlay mesh repair | Open (16) Lap. (4) | Yes | Onlay | synthetic, non- absorbable | 45.0% | 10.0% | NR | 6 m | NR | NR | NR |
| Mäkäräinen- Uhlbäck** 2021 | Finland | 2007–2017 | 18 (KH) | 70 ± 9 | 44,4% | Keyhole | Open (7) Lap. (11) | Yes | NR | NR | 33.3% | 11.1% | 22.2% | 49 m ± 34 | NR | 17.8 ± 50.1 days | 5.6% |
| 10 (SB) | 77 ± 6 | 60,0% | Sugar- baker | Open (2) Lap. (8) | Yes | NR | NR | 10.0% | 0.0% | 10.0% | 27 m ± 21 | NR | 6.3 ± 3.7 days | 0.0% | |||
| Rodriguez- Faba 2011 | Spain | 2000–2006 | 19 | 63 (49–79) | 84% | Re- location | Open | Yes (§) | Intra- peritoneal | large pore, light weight | 26% | 5% | 21% | 55 m | NR | 7 d(1–25) | 5% |
| Safadi 2004 | USA | 1998–2001 | 5 | 66 (54–77) | 100% | Keyhole | Lap | Yes | Intra- peritoneal | ePTFE | 0% | 0% | 80% | 11.6 m (6–10) | Clinical | 4.4 d (2–6) | 0% |
| Tully 2019 | Germany | 2009–2015 | 40 | NR | 63% | 3D funnel shape | Open | Yes | Intra- peritoneal | large pore, light weight | 3% | 3% | 7% | 29 m (IQR 16–63) | Clinical + US | NR | 0% |
*Numbers within brackets indicate ranges, unless otherwise stated
†Mesh was used at the previous stoma site for 2 patients with large defects
‡A lateral approach was used, where only the lateral part of the parastomal hernia was covered with mesh
§Mesh was used at previous stoma site
**National cohort
NR not reported, lap. laparoscopic, compl. complication, rec. recurrence, m months, IQR interquartile range, CT computed-tomography scan, US ultrasonography, CD Clavien-Dindo
Study characteristics, surgical details and postoperative outcomes of included conference abstracts
| Study characteristics* | Surgical details | Postoperative outcomes* | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Author | Country | Study period | Sample size | Mean age | Male (%) | Surgical technique | Approach | Mesh repair | Mesh position | Post- operative compl. rate | Rec. rate | Length of follow-up | Type of follow-up | Length of stay |
| Antor 2017 | France | 2006–2015 | 9 | 63 (59–83) | NR | NR | Lap | Yes | Intra-peritoneal | 0% | 22% | 27 m (7–106) | Clinical + PC | 6d (4–13) |
| Davis 2012 | Canada | 2005–2010 | 11 | 63.9 (47–79) | 36% | NR | Lap | Yes | NR | NR | 27% | 19.1 m (1–62) | NR | 6.3d (1–12) |
| Jaipuria 2020 | India | 2018–2019 | 6 | 67 | 67% | MS | RA | Yes | Intra-peritoneal | NR | 0% | 10 m | NR | 2d |
| Shakir 2020 | USA | 2017–2019 | 7 | 71 | 29% | Keyhole | RA | Yes | Intra-peritoneal | 29% | 0% | 90 d | NR | 4d |
| Von Bodman 2012 | Germany | 2009–2011 | 13 | 70 | 54% | 3D funnel shape | Open | Yes | Intra-peritoneal | 31% | 8% | 23 m | Clinical + US | NR |
*Numbers within brackets indicate ranges, unless otherwise stated
NR not reported, MS modified Sugarbaker, lap. laparoscopic, RA robotic-assisted, compl. complications, rec. recurrence, m months, PC phone call, US ultrasonography
Study characteristics, surgical details and postoperative outcomes of literature on prophylactic mesh placement in primary radical cystectomy and ileal conduit urinary diversion
| General characteristics* | Surgical details* | Postoperative outcome* | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Author & Year | Country | Study period | Study design | Sample size | Mean age | Male (%) | MIN- ORS | Tech- nique | Appr | Mesh position | Mesh type | Length of follow-up | Type of follow-up | PSH rate | Compl. rate | Mesh- related compl |
| Donahue 2016 | USA | 2013–2015 | RS | 33 | NR | 51.5% | Key-hole | Open | Retro-rectus | large pore, light weight | 297 days | Clinical + CT | Clin: 3% CT: 18.2% | NR | 0.0% | |
| Liedberg 2020 | Sweden | 2012–2017 | RCT | C:124 M:118 | C: 71 M: 71 | C: 79% M: 77% | Key-hole | Open | Retro-rectus | large pore, light weight | 3 years | Clinical + CT | C: 29.3% M: 10.2% | C: 41.5%M: 43.1% | NR | |
| Styrke 2015 | Sweden | 2003–2012 | RS | 58 | 69 ± 7 | 59.0% | Key-hole | Open | Retro-rectus | large pore, light weight | 32mon | Clinical + CT | 14.0% | NR | 0.0% | |
| Tenzel 2018 | USA | 2010–2017 | RS | C: 20 M: 18 | 68 | 74.0% | Key-hole | Rob | Retro-rectus | synthetic resorbable/bio | C: 21mon M: 11mon | CT | C: 5% M: 0% | NR | 0.0% | |
*: numbers within brackets indicate ranges, unless otherwise stated
CA conference abstract, C control (no mesh), M mesh, RS retrospective PS prospective, NC nationwide cohort, NR not reported, m months, CT Computed-Tomography scan, SD standard deviation, US ultrasonography
Summary of MINOR-score for all included full-text articles
| MINORS | Items* | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Article | A clearly stated aim | Inclusion of consecutive patients | Prospective collection of data | Endpoints appropriate to the aim | Unbiased assessment of the study endpoint | Appropriate follow-up period | Loss to follow-up < 5% | Prospective calculation of study size | Total |
| Franks 2001 | 2 | 0 | 0 | 1 | 0 | 2 | 0 | 0 | 5 |
| Helal 1997 | 2 | 0 | 0 | 1 | 0 | 2 | 0 | 0 | 5 |
| Ho 2004 | 2 | 1 | 1 | 1 | 0 | 2 | 0 | 0 | 7 |
| Lopez-Cana 2021 | 2 | 1 | 2 | 2 | 0 | 2 | 1 | 0 | 10 |
| Mäkäräinen- Uhlbäck 2021 | 2 | 0 | 0 | 2 | 0 | 2 | 1 | 0 | 7 |
| Rodriguez-Faba 2011 | 2 | 2 | 1 | 1 | 0 | 2 | 0 | 0 | 8 |
| Safadi 2004 | 2 | 1 | 1 | 1 | 0 | 2 | 2 | 0 | 9 |
| Tully 2019 | 2 | 2 | 1 | 2 | 0 | 2 | 1 | 0 | 10 |
*For each item a score of 0 (not reported), 1 (reported but inadequate), or 2 (reported and adequate) can be given. The global ideal score for non-comparative studies is defined as being 16
MINORS methodological index for non-randomized studies